MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 13, 2022

Total Value ($000): $372,610 (100.0% shares, 0.0% debt)

Holdings (37)

CGEM Cullinan Oncology, Inc. 21.5%

Value ($000) $80,077 Shares 7,648,268 Est. Cost $40.60 Unrealized -66.7%

— iTeos Therapeutics, Inc. 15.1%

Value ($000) $56,184 Shares 1,745,943 Est. Cost $24.67 Unrealized —

— Merus N.V. 6.5%

Value ($000) $24,311 Shares 919,482 Est. Cost $17.60 Unrealized —

— Repare Therapeutics, Inc. 6.3%

Value ($000) $23,351 Shares 1,639,849 Est. Cost $31.02 Unrealized —

— Harpoon Therapeutics, Inc. 4.3%

Value ($000) $15,888 Shares 3,196,707 Est. Cost $14.79 Unrealized —

NTLA Intellia Therapeutics, Inc. 3.1%

Value ($000) $11,584 Shares 159,409 Est. Cost $151.40 Unrealized -44.0%

HOWL Werewolf Therapeutics, Inc. 2.8%

Value ($000) $10,507 Shares 2,388,011 Est. Cost $13.70 Unrealized -48.9%

BCRX Biocryst Pharmaceuticals Inc. 2.8%

Value ($000) $10,392 Shares 639,089 Est. Cost $15.77 Unrealized +1.7%

— Turning Point Therapeutics, Inc. 2.5%

Value ($000) $9,434 Shares 351,350 Est. Cost $40.61 Unrealized —

— TCR2 Therapeutics, Inc. 2.5%

Value ($000) $9,304 Shares 3,370,982 Est. Cost $14.28 Unrealized —

GERN Geron Corporation 2.2%

Value ($000) $8,363 Shares 6,149,277 Est. Cost $1.32 Unrealized -15.3%

CYTK Cytokinetics Inc. 2.2%

Value ($000) $8,254 Shares 224,246 Est. Cost $29.44 Unrealized +20.7%

CRNX Crinetics Pharmaceuticals Inc. 2.2%

Value ($000) $8,049 Shares 366,676 Est. Cost $21.72 Unrealized -6.8%

TVTX Travere Therapeutics Inc. 1.9%

Value ($000) $7,163 Shares 277,950 Est. Cost $18.37 Unrealized +44.5%

HRMY Harmony Biosciences Hldgs Inc. 1.8%

Value ($000) $6,690 Shares 137,517 Est. Cost $32.20 Unrealized +26.7%

— G1 Therapeutics, Inc. 1.7%

Value ($000) $6,512 Shares 856,798 Est. Cost $25.71 Unrealized —

MIRM Mirum Pharmaceuticals Inc. 1.7%

Value ($000) $6,353 Shares 288,531 Est. Cost $16.26 Unrealized +25.4%

— Reata Pharmaceuticals inc-a 1.6%

Value ($000) $5,897 Shares 180,000 Est. Cost $32.76 Unrealized —

— YmAbs Therapeutics, Inc. 1.4%

Value ($000) $5,271 Shares 443,702 Est. Cost $30.56 Unrealized —

ARQT Arcutis Biotherapeutics inc 1.3%

Value ($000) $4,979 Shares 258,500 Est. Cost $16.92 Unrealized 0.0%

ADCT ADC Therapeutics, Inc. 1.3%

Value ($000) $4,912 Shares 334,384 Est. Cost $33.59 Unrealized -52.8%

FOLD Amicus Therapeutics Inc. 1.3%

Value ($000) $4,693 Shares 495,603 Est. Cost $10.23 Unrealized -8.3%

— Verastem, Inc. 1.2%

Value ($000) $4,575 Shares 3,244,650 Est. Cost $2.94 Unrealized —

— Oncorus, Inc. 1.1%

Value ($000) $4,231 Shares 2,377,031 Est. Cost $32.33 Unrealized —

AXSM Axsome Therapeutics Inc. 1.1%

Value ($000) $4,132 Shares 99,834 Est. Cost $38.97 Unrealized -20.5%

— ESSA Pharma, Inc. 1.1%

Value ($000) $4,084 Shares 660,892 Est. Cost $8.00 Unrealized —

— Epizyme, Inc. 1.1%

Value ($000) $3,939 Shares 3,425,202 Est. Cost $15.19 Unrealized —

RVMD Revolution Medicines, Inc. 1.0%

Value ($000) $3,726 Shares 146,041 Est. Cost $29.11 Unrealized -25.2%

RLMD Relmada Therapeutics inc 1.0%

Value ($000) $3,725 Shares 138,000 Est. Cost $20.68 Unrealized 0.0%

ACAD Acadia Pharmaceuticals Inc 1.0%

Value ($000) $3,675 Shares 151,750 Est. Cost $20.83 Unrealized +16.2%

— Avadel Pharmaceuticals Plc 0.8%

Value ($000) $2,816 Shares 412,363 Est. Cost $9.53 Unrealized —

PHAT Phathom Pharmaceuticals inc 0.7%

Value ($000) $2,631 Shares 193,326 Est. Cost $16.15 Unrealized 0.0%

— Karuna Therapeutics inc 0.7%

Value ($000) $2,536 Shares 20,000 Est. Cost $126.80 Unrealized —

NEO Neogenomics Inc. 0.4%

Value ($000) $1,647 Shares 135,573 Est. Cost $46.29 Unrealized -54.5%

— Inozyme Pharma Inc. 0.3%

Value ($000) $1,206 Shares 294,980 Est. Cost $11.59 Unrealized —

— AVROBIO, Inc. 0.2%

Value ($000) $855 Shares 647,918 Est. Cost $5.58 Unrealized —

BDTX Black Diamond Therapeutics, Inc. 0.2%

Value ($000) $664 Shares 239,888 Est. Cost $9.87 Unrealized -63.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$80,077	21.5%	$40.60	-66.7%	Common	230031106
—	iTeos Therapeutics, Inc.	1,745,943	$56,184	15.1%	$24.67	—	Common	46565G104
—	Merus N.V.	919,482	$24,311	6.5%	$17.60	—	Common	N5749R100
—	Repare Therapeutics, Inc.	1,639,849	$23,351	6.3%	$31.02	—	Common	760273102
—	Harpoon Therapeutics, Inc.	3,196,707	$15,888	4.3%	$14.79	—	Common	41358P106
NTLA	Intellia Therapeutics, Inc.	159,409	$11,584	3.1%	$151.40	-44.0%	Common	45826J105
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$10,507	2.8%	$13.70	-48.9%	Common	95075A107
BCRX	Biocryst Pharmaceuticals Inc.	639,089	$10,392	2.8%	$15.77	+1.7%	Common	09058V103
—	Turning Point Therapeutics, Inc.	351,350	$9,434	2.5%	$40.61	—	Common	90041T108
—	TCR2 Therapeutics, Inc.	3,370,982	$9,304	2.5%	$14.28	—	Common	87808K106
GERN	Geron Corporation	6,149,277	$8,363	2.2%	$1.32	-15.3%	Common	374163103
CYTK	Cytokinetics Inc.	224,246	$8,254	2.2%	$29.44	+20.7%	Common	23282W605
CRNX	Crinetics Pharmaceuticals Inc.	366,676	$8,049	2.2%	$21.72	-6.8%	Common	22663K107
TVTX	Travere Therapeutics Inc.	277,950	$7,163	1.9%	$18.37	+44.5%	Common	89422G107
HRMY	Harmony Biosciences Hldgs Inc.	137,517	$6,690	1.8%	$32.20	+26.7%	Common	413197104
—	G1 Therapeutics, Inc.	856,798	$6,512	1.7%	$25.71	—	Common	3621LQ109
MIRM	Mirum Pharmaceuticals Inc.	288,531	$6,353	1.7%	$16.26	+25.4%	Common	604749101
—	Reata Pharmaceuticals inc-a	180,000	$5,897	1.6%	$32.76	—	Common	75615P103
—	YmAbs Therapeutics, Inc.	443,702	$5,271	1.4%	$30.56	—	Common	984241109
ARQT	Arcutis Biotherapeutics inc	258,500	$4,979	1.3%	$16.92	0.0%	Common	03969K108
ADCT	ADC Therapeutics, Inc.	334,384	$4,912	1.3%	$33.59	-52.8%	Common	H0036K147
FOLD	Amicus Therapeutics Inc.	495,603	$4,693	1.3%	$10.23	-8.3%	Common	03152W109
—	Verastem, Inc.	3,244,650	$4,575	1.2%	$2.94	—	Common	92337C104
—	Oncorus, Inc.	2,377,031	$4,231	1.1%	$32.33	—	Common	68236R103
AXSM	Axsome Therapeutics Inc.	99,834	$4,132	1.1%	$38.97	-20.5%	Common	05464T104
—	ESSA Pharma, Inc.	660,892	$4,084	1.1%	$8.00	—	Common	29668H708
—	Epizyme, Inc.	3,425,202	$3,939	1.1%	$15.19	—	Common	29428V104
RVMD	Revolution Medicines, Inc.	146,041	$3,726	1.0%	$29.11	-25.2%	Common	76155X100
RLMD	Relmada Therapeutics inc	138,000	$3,725	1.0%	$20.68	0.0%	Common	75955J402
ACAD	Acadia Pharmaceuticals Inc	151,750	$3,675	1.0%	$20.83	+16.2%	Common	004225108
—	Avadel Pharmaceuticals Plc	412,363	$2,816	0.8%	$9.53	—	ADR	05337M104
PHAT	Phathom Pharmaceuticals inc	193,326	$2,631	0.7%	$16.15	0.0%	Common	71722W107
—	Karuna Therapeutics inc	20,000	$2,536	0.7%	$126.80	—	Common	48576A100
NEO	Neogenomics Inc.	135,573	$1,647	0.4%	$46.29	-54.5%	Common	64049M209
—	Inozyme Pharma Inc.	294,980	$1,206	0.3%	$11.59	—	Common	45790W108
—	AVROBIO, Inc.	647,918	$855	0.2%	$5.58	—	Common	05455M100
BDTX	Black Diamond Therapeutics, Inc.	239,888	$664	0.2%	$9.87	-63.0%	Common	09203E105